1. Home
  2. SOWG vs MYO Comparison

SOWG vs MYO Comparison

Compare SOWG & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sow Good Inc.

SOWG

Sow Good Inc.

N/A

Current Price

$2.90

Market Cap

69.9M

ML Signal

N/A

Logo Myomo Inc.

MYO

Myomo Inc.

HOLD

Current Price

$1.48

Market Cap

68.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOWG
MYO
Founded
2010
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Industrial Specialties
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
69.9M
68.9M
IPO Year
2011
2017

Fundamental Metrics

Financial Performance
Metric
SOWG
MYO
Price
$2.90
$1.48
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
16.2K
456.4K
Earning Date
05-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,000,000,000.00
Revenue This Year
N/A
$9.10
Revenue Next Year
N/A
$13.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40814.79
52 Week Low
$0.10
$0.61
52 Week High
$4.45
$1.89

Technical Indicators

Market Signals
Indicator
SOWG
MYO
Relative Strength Index (RSI) 41.81 55.67
Support Level $2.45 $0.92
Resistance Level $3.65 $1.89
Average True Range (ATR) 0.39 0.11
MACD -0.05 -0.01
Stochastic Oscillator 11.60 63.57

Price Performance

Historical Comparison
SOWG
MYO

About SOWG Sow Good Inc.

Sow Good Inc is engaged in manufacturing and marketing freeze-dried fruits, vegetables, snacks, smoothies, and soups. The company also sells gluten-free products under the Sow Good brand. The company is developing a freeze-dried candy market and snack manufacturing to provide consumers with flavorful freeze-dried treats. The company operates in one reportable segment, reflecting its capital-light business model under which it earns proceeds from the sale of freeze-dried candy products.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.

Share on Social Networks: